Market Overview

The Global Intracranial Aneurysm Market was valued at USD 1,128.3 million in 2023 and is expected to reach USD 2,202.7 million by 2031 while growing at a CAGR of 8.7% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global intracranial aneurysm market growth. An intracranial aneurysm, commonly referred to as a cerebral or brain aneurysm, manifests as a localized and abnormal bulging or ballooning of a blood vessel within the brain. It is identified by a weakened area in the vessel wall, typically an artery, leading to the formation of a sac-like structure.

The rising incidence of intracranial aneurysms and technological advancements in diagnostic tools and treatment options drive substantial growth in the intracranial aneurysm market. However, obstacles such as the high cost of treatment and the risk of complications may hinder the market's expansion.

Furthermore, the global intracranial aneurysm industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Type Analysis

The Global Intracranial Aneurysm Market is segmented among Endovascular Coiling, Surgical Clipping, Flow Diverters, and Other Types, based on Type. In 2023, Endovascular Coiling accounted for the majority of the market share*.

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By End User Analysis

The Global Intracranial Aneurysm Market is segmented among Hospitals, Ambulatory Surgical Centers, and Other End-users, based on end user. In 2023, Hospitals accounted for the majority of the market share*. 

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Intracranial Aneurysm Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Stryker, B. Braun Melsungen AG, MicroPort Scientific Corporation, Medtronic, Terumo Corporation, Integra LifeSciences Corporation, Johnson & Johnson, RAUMEDIC AG, Microvention Inc., and Codman Neuro (Integra Lifesciences).

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Intracranial Aneurysm Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Intracranial Aneurysm Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Intracranial Aneurysm Market Segmentation, By Type

• Global Intracranial Aneurysm Market Share Analysis, By Type

• Global Intracranial Aneurysm Market Growth Analysis, By Type

• Global Intracranial Aneurysm Market Trends, By Type

o Endovascular Coiling

o Surgical Clipping

o Flow Diverters

o Other Types

6. Global Intracranial Aneurysm Market Segmentation, By End User

• Global Intracranial Aneurysm Market Share Analysis, By End User

• Global Intracranial Aneurysm Market Growth Analysis, By End User

• Global Intracranial Aneurysm Market Trends, By End User

o Hospitals

o Ambulatory Surgical Centers

o Other End-users

7. Global Intracranial Aneurysm Market Segmentation, By Region

• Global Intracranial Aneurysm Market Share Analysis, By Region

• Global Intracranial Aneurysm Market Growth Analysis, By Region

• Global Intracranial Aneurysm Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Stryker*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• B. Braun Melsungen AG

• MicroPort Scientific Corporation

• Medtronic

• Terumo Corporation

• Integra LifeSciences Corporation

• Johnson & Johnson

• RAUMEDIC AG

• Microvention Inc.

• Codman Neuro (Integra Lifesciences) 

*Similar analysis will be provided for each company listed above.